Mesoblast (MESO) Goodwill (2015 - 2023)

Mesoblast's (MESO) quarterly Goodwill came in at $2.1 million in Q2 2023, down 84.89% year-on-year from $13.9 million in Q2 2022, and down 84.89% quarter-over-quarter from $13.9 million in Q2 2022.

Mesoblast (MESO) Goodwill (2015 - 2023) Analysis & Trends

Mesoblast has disclosed Goodwill across 4 years of filings, most recently posting $2.1 million for Q2 2023.

  • Goodwill for Q2 2023 came in at $2.1 million, down 84.89% year-over-year; the trailing twelve-month figure through Jun 2023 was $2.1 million (down 84.89% YoY), and the FY2023 annual result was $2.1 million, down 84.89% from the prior year.
  • Goodwill came in at $2.1 million for Q2 2023 at Mesoblast, down from $13.9 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $118.4 million in Q2 2021 to a low of $2.1 million in Q2 2023.
  • The 3-year median for Goodwill is $13.9 million (2022), against an average of $44.8 million.
  • Across the five-year window, Goodwill slumped 88.26% in 2022 and tumbled 84.89% in 2023, its largest moves.
  • Mesoblast's Goodwill stood at $118.4 million in 2021, then plunged by 88.26% to $13.9 million in 2022, then sank by 84.89% to $2.1 million in 2023.
  • The last three Goodwill figures came in at $2.1 million (Q2 2023), $13.9 million (Q2 2022), and $118.4 million (Q2 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Mesoblast 21.68 Bn 21.55 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2023 2.10 Mn
Jun 30, 2022 13.90 Mn
Jun 30, 2021 118.40 Mn
Jun 30, 2015 2.10 Mn